Ninety to 95% of drugs entering clinical trials never reach the market, weeded out by insufficient efficacy, safety concerns, or poor pharmacokinetics — a filter the gray market bypasses entirely.
Snapshot · The Peter Attia Drive
Ninety to 95% of drugs entering clinical trials never reach the market, weeded out by insufficient efficacy, safety concerns, or poor pharmacokinetics — a filter the gray market bypasses entirely.
Where this was said
At 51:30 · chapter starts 49:10
For listeners still on the fence, Peter offers one definitive test: what observation would prove a given peptide claim wrong? If the answer is none — if every negative result gets explained away by the wrong dose, bad timing, inferior supplier, or improper stacking — the hypothesis is not falsifiable. And a non-falsifiable hypothesis cannot be corrected by evidence. [1] — Peter Attia "Ask one question of any peptide advocate: what evidence would prove this claim wrong? If every disappointing result gets attributed to wron…" 49:30 This is precisely what conventional drug development enforces: show efficacy in humans, define who benefits, characterize the dose and pharmacokinetics, understand the risks, then decide how it should be used. Adoption follows evidence. The gray-market wellness space has run this order completely backwards — widespread use has preceded the evidence on the assumption that science will eventually catch up. For many of these compounds, it hasn't, and the tell is that the list of claims keeps growing while foundational questions remain open. Peter acknowledges the pharmaceutical industry's failures — but notes those failures happen inside a process built to catch them, one that eliminates 90 to 95% of drug candidates before they ever reach patients. [2] — Peter Attia "A claim which can't fail isn't a scientific claim. And a field that expands rather than narrows its claims over time is moving in the wrong…" 52:10 The episode closes with one of its most memorable lines: a claim that can't fail isn't a scientific claim, and a field that expands rather than narrows its claims over time is doing marketing, not medicine. Hope, he says, deserves a lot more than that.
Ask one question of any peptide advocate: what evidence would prove this claim wrong? If every disappointing result gets attributed to wrong dose, bad supplier, wrong timing, or improper stacking, the hypothesis is not falsifiable — and a non-falsifiable claim is not a scientific claim.
When applying for Medicaid to cover nursing home costs, there is a 5-year look-back period that can disqualify applicants who gave away or spent down assets.
A broken pipe filled the Bad Friends studio with what the hosts identified as hydrogen sulfide — microscopic fecal aeroparticles — that the crew denied smelling.
Fei-Fei Li's father's liver surgery performed by a da Vinci robot resulted in 10 times less blood loss than a typical open liver surgery, thanks to laparoscopic precision.
Approximately 115 million adults in the US currently have prediabetes, most of whom are unaware, according to the Lingo sponsor segment.
Drug overdose deaths in the US fell from 110,000 to 80,000 in 2024, and then to roughly 70,000 — the largest single-year drop the CDC has ever recorded.
Men's overdose death rate fell 27% in a single year, outpacing the 23% drop for women.
The steepest decline in overdose deaths was among 15–24-year-olds, whose rate fell 37%.
Fei-Fei Li observed that on a given hospital shift, nurses walk miles just to fetch medicine and supplies, illustrating a clear use case for assistive robotics in healthcare.
Before becoming the Bachelorette, Robby's wife Gabby Windey worked as an ICU nurse for years.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.